3D echocardiography plays an important role in assessing and intervening in valve diseases. It can evaluate valve anatomy in detail, guide interventional procedures such as MitraClip and balloon valvuloplasty, and monitor outcomes. Real-time 3D TEE is especially useful for quantifying mitral regurgitation and measuring the mitral valve area during balloon valvuloplasty. 3D imaging also helps with patient selection and guidance for transcatheter aortic valve implantation.
3. 3D Echocardiography 2015: State of the Art
• LV Volume, Mass, radial, longitudinal, twist, torsion
• AS TAVI, preinterventional, intra-, postprocedural, complications
• MR differential diagnosis MitraClip®, Cardioband ®, parav. leak
• LAA preinterventional, intraprocedural
• ASD preinterventional, intraprocedural
• TR preinterventional, intraprocedural
TEE: AS diagnosis quantitative
TTE: Pacemaker leads
TTE and TEE: AC
4. LỰA CHỌN VÀ ĐÁNH GIÁ BỆNH NHÂN KẸP
SỬA VAN HAI LÁ QUA DA MITRACLIP -
CẬP NHẬT VỀ VAI TRÒ CỦA SIÊU ÂM TIM 3D
QUA THỰC QUẢN 3D
Select and assess patients for MitraClip:
Update on the roles of 3D TEE
5. Echocardiography is a key modality for MR
Etiology
Severity
Symptom
LV function
Echo
Echo
I nterviewing
Echo
2
13. MitraClip anatomical patient selection
considerations
• Moderate to severe MR
(Grade 3 or more out of 4 grades)
• Pathology in A2-P2 area
• Coaptation length > 2 mm
(depending on leaflet mobility)
• Coaptation depth < 11 mm
• Flail gap < 10 mm
• Flail width < 15 mm
• Mitral valve orifice area > 4cm2
(depending on leaflet mobility)
• Mobile leaflet length > 1 cm
Recommended criteria1
1. The current patient considerations are based on EVEREST II and
commercial European experience to date. The MitraClip Patient
Selection Coniderations document has been endorsed by Expert
Opinion (Crossroads institute).
FMR
DMR
14.
15. 1. Anatomic criteria.
2. Clinical criteria
EVEREST II: need to select patients with potential
clinical benefit.
How to identify suitable patients?
16. 1. Severe heart failure, despite optimal medical
therapy.
2. CRT non-responders.
3. Degenerative MR, denied for surgery.
4. Severe LV dysfunction, refractory to medical
therapy.
Patient groups in which significant
clinical benefits have been reported
28. Quantification of MV prolapse
2D 3D analysis
Lateral Mediall
Anterior
Posterior
A
P
L M
L M A P
Gap
Left ventricle
Left atrium
0°: 4chamber
Width
Left atrium
Left ventricle
45°: Bi-commissure
Izumo, Shiota, et al. Am J Cardiol. 2013; 111:588-94. 15
32. Pre-procedure
l Case selection is the key to success
l Avoid
n cleft
n PML length less than 7 mm
n Pre-existing MS
l Central position
n FMR: with coaptation (no gap)
n DMR: not large gap or large flail width
How to simplify the procedure
52. ✓ Confirmation of diagnosis
✓ Quantitation of stenosis severity
✓ Consequences
✓ Analysis of valve anatomy
Echocardiography: Major role in
decision making for mitral stenosis
55. Parasternal short-axis view
valve thickness (maximum and heterogeneity)
commissural fusion
extension and location of localized bright zones (fibrous nodules or
calcification)
Parasternal long-axis view
valve thickness
extension of calcification
valve pliability
subvalvular apparatus (chordal thickening, fusion, or shortening)
Apical two-chamber view
subvalvular apparatus (chordal thickening, fusion, or shortening)
Detail each component and summarize in a score
Valve Anatomy
56. How to Grade Mitral Stenosis
✓ Normal MVA is 4.0-5.0 cm2
✓ MVA >1.5 cm2 does not produce significant symptoms
✓ As severity increases, cardiac output decreases and fails to
increase during exercise.
57. The most validated and commonly used TTE criterion is
Wilkins Score:
✓ Severity and extent of leaflet calcification
✓ Leaflet thickening
✓ Leaflet mobility
✓ Subvalvular apparatus
Patient selection for PMBV
58. Wilkins Score - Splitability score
An inverse relationship exists between the total splitability score and PMBV success, with the
cutpoint of ≤8 reflecting best short- and long-term results.
Wilkins score alone does not appear to be a good predictor of post-PMBV mitral regurgitation
(MR), but rather the degree of commissural opening
60. TEE before PMBV is useful to screen for LA or LAA thrombus or dense spontaneous echo
contrast, especially in A-fib.
Information of LA thrombus
61.
62. Clinical research
Non-invasive assessment of mitral valve area during
percutaneous balloon mitral valvuloplasty: role
of real-time 3D echocardiography
José Zamoranoa,
*, Leopoldo Perez de Islaa
, Lissa S
ugengb
, Pedro Cordeiroa
,
José Luis Rodrigoa
, Carlos Almeriaa
, Lynn Weinert b
, Ted Feldmanb
,
Carlos Macayaa
, Roberto M. Langb
, Rosana Hernandez Antolina
a
Echocardiography Laborat ory of t he Hospit al Clı́nico de S
an Carlos, Inst it ut o Cardiovascular, 28040 Madrid, S
pain
b
Universit y Hospit al of Chicago, Chicago, US
A
Received 13 May 2004; revised 3 S
eptember 2004; accepted 9 S
eptember 2004
S
ee page 2073 for the editorial comment on this article (doi:10.1016/j .ehj .2004.10.001)
European Heart Journal (2004) 25, 2086– 2091
J Am Soc Echocardiogr 2003;16:841-9
European Heart Journal (2004) 25, 2086–2091
65. TEE in Percutaneous Aortic Valve Implantation
❖Preliminary TTE assessment.
❖TEE imaging and guided valve deployment.
❖ Early TTE assessment after device deployment.